For Marti Jett, the chief of molecular pathology at Walter Reed Army Institute of Research in Silver Spring, Md., catching things early is essentially part of her job description. As an Army researcher, she’s interested in finding ways to rapidly identify patients who have been exposed to pathogens that could be used in warfare. By the time a patient is clinically diagnosed with anthrax, for example, estimates are that person has only a 12 percent chance of beating the disease when treated with the antibiotic ciproflaxin.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.